114 related articles for article (PubMed ID: 17044034)
1. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
[TBL] [Abstract][Full Text] [Related]
2. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.
Xiao W; Jiang F; Wang Z
Prostate; 2006 Jan; 66(1):1-12. PubMed ID: 16114057
[TBL] [Abstract][Full Text] [Related]
3. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F; Ai J; Xiao W; Wang Z
Cancer Lett; 2007 Aug; 253(2):265-72. PubMed ID: 17395368
[TBL] [Abstract][Full Text] [Related]
4. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.
Qiao Z; Wang D; Hahn J; Ai J; Wang Z
Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884
[TBL] [Abstract][Full Text] [Related]
5. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
[TBL] [Abstract][Full Text] [Related]
6. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
10. Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
Cai L; Wang D; Fisher AL; Wang Z
Biochem Biophys Res Commun; 2014 May; 447(2):292-8. PubMed ID: 24727455
[TBL] [Abstract][Full Text] [Related]
11. Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.
Su F; Correa BR; Luo J; Vencio RZ; Pascal LE; Wang Z
Cancer Microenviron; 2013 Dec; 6(3):247-61. PubMed ID: 23440596
[TBL] [Abstract][Full Text] [Related]
12. ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.
Liu L; Ai J; Xiao W; Liu J; Wang Y; Xin D; He Z; Guo Y; Wang Z
Prostate; 2010 May; 70(7):797-805. PubMed ID: 20166137
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.
Xiao W; Zhang Q; Jiang F; Pins M; Kozlowski JM; Wang Z
Cancer Res; 2003 Aug; 63(15):4698-704. PubMed ID: 12907652
[TBL] [Abstract][Full Text] [Related]
14. Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.
Wan X; Ji W; Mei X; Zhou J; Liu JX; Fang C; Xiao W
PLoS One; 2010 Feb; 5(2):e9118. PubMed ID: 20161747
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.
Yang T; Jing Y; Dong J; Yu X; Zhong M; Pascal LE; Wang D; Zhang Z; Qiao B; Wang Z
Prostate; 2018 Nov; 78(15):1201-1212. PubMed ID: 30009504
[TBL] [Abstract][Full Text] [Related]
16. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
[TBL] [Abstract][Full Text] [Related]
17. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
18. EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.
Ai J; Pascal LE; Wei L; Zang Y; Zhou Y; Yu X; Gong Y; Nakajima S; Nelson JB; Levine AS; Lan L; Wang Z
Oncogene; 2017 Apr; 36(15):2054-2065. PubMed ID: 27721405
[TBL] [Abstract][Full Text] [Related]
19. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.
Johnstone RW; Gerber M; Landewe T; Tollefson A; Wold WS; Shilatifard A
Mol Cell Biol; 2001 Mar; 21(5):1672-81. PubMed ID: 11238904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
